stockrowIntellia Therapeutics, Inc. (NTLA) vs Novavax, Inc. (NVAX)
- Intellia Therapeutics, Inc. NTLA 11.27 +1.53%
- Novavax, Inc. NVAX 10.76 +10.02%
Intellia Therapeutics, Inc. and Novavax, Inc. are both Biotechnology companies. Intellia Therapeutics, Inc. and Novavax, Inc. are of similar size ($1.6B and $1.6B). Intellia Therapeutics, Inc. grew revenue faster over the last twelve months: −8.07% against −61.3%. Novavax, Inc. has the higher net margin (−18.6% vs −805.8%) and the higher return on invested capital (0.00% vs −195.3%). Across the 16 metrics below, Novavax, Inc. leads on 13 and Intellia Therapeutics, Inc. on 3.
Valuation
Profitability
| Metric | NTLA | NVAX | Biotechnology median |
|---|---|---|---|
| Gross margin | 100.00% | 78.01% | 68.51% |
| Operating margin | (821.24%) | (21.23%) | 0.00% |
| Net margin | (805.75%) | (18.64%) | 0.00% |
| Free cash flow margin | (671.57%) | (58.05%) | 0.00% |
| Return on equity | (62.60%) | 41.08% | (51.96%) |
| Return on assets | (46.63%) | (7.42%) | (46.06%) |
| Return on invested capital | (195.32%) | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack